EMA Application withdrawn: Treprostinil SciPharm Sàrl (treprostinil) — SciPharm Sàrl

View source ↗

Summary

The EMA indicates that the application for treprostinil by SciPharm Sàrl has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Treprostinil (treprostinil)

Snippet

Status: Application withdrawn. Therapeutic area: Hypertension, Pulmonary. MAH: SciPharm Sàrl. Decision date: 21/09/2018